CD۴۷ and SIGLEC۱۵ Immune Checkpoint Genes Expression and Apoptotic Pathway Activation Following Photodynamic Therapy with Zinc Phthalocyanine in the B-CPAP Thyroid Cancer Cell Line

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 92

فایل این مقاله در 11 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_JABS-16-2_005

تاریخ نمایه سازی: 13 خرداد 1405

چکیده مقاله:

Background & Objectives: Thyroid cancer is one of the most prevalent endocrine malignancies. Photodynamic therapy is an emerging minimally invasive therapeutic modality that employs a photosensitizer in conjunction with light irradiation to induce targeted cytotoxicity. The present study was designed to evaluate the effects of zinc phthalocyanine-mediated photodynamic therapy on the expression of immune checkpoint genes CD۴۷ and SIGLEC۱۵, as well as key genes involved in apoptotic pathways, in papillary thyroid cancer cells. Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a ۶۷۵ nm diode laser at a fluence of ۲۴ J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD۴۷, SIGLEC۱۵, Caspase-۳, Caspase-۹ and Bcl-۲ genes were quantified using quantitative real-time polymerase chain reaction. Results:  Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-۳ and Caspase-۹ transcripts alongside the downregulation of Bcl-۲ expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD۴۷ and SIGLEC۱۵ was observed following treatment. Conclusion:  The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD۴۷ and SIGLEC۱۵ in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion. Keywords: Thyroid cancer, Photodynamic therapy, Zinc phthalocyanine, Immune checkpoints, Apoptosis CD۴۷ and SIGLEC۱۵ Immune Checkpoint Genes Expression and Apoptotic Pathway Activation Following Photodynamic Therapy with Zinc Phthalocyanine in the B-CPAP Thyroid Cancer Cell Line Photodynamic Therapy, Immune Checkpoints, and Apoptosis in Thyroid Cancer Background & Objectives: Thyroid cancer is one of the most prevalent endocrine malignancies. Photodynamic therapy is an emerging minimally invasive therapeutic modality that employs a photosensitizer in conjunction with light irradiation to induce targeted cytotoxicity. The present study was designed to evaluate the effects of zinc phthalocyanine-mediated photodynamic therapy on the expression of immune checkpoint genes CD۴۷ and SIGLEC۱۵, as well as key genes involved in apoptotic pathways, in papillary thyroid cancer cells. Materials & Methods: The human papillary thyroid cancer cell line B-CPAP was exposed to various concentrations of zinc phthalocyanine and subsequently irradiated using a ۶۷۵ nm diode laser at a fluence of ۲۴ J/cm². Cellular viability, reflecting mitochondrial metabolic activity, was assessed using the MTT assay. The relative mRNA expression levels of CD۴۷, SIGLEC۱۵, Caspase-۳, Caspase-۹ and Bcl-۲ genes were quantified using quantitative real-time polymerase chain reaction. Results:  Zinc phthalocyanine-mediated photodynamic therapy markedly reduced the viability of B-CPAP cells. The treatment activated the intrinsic apoptotic pathway, as demonstrated by the significant upregulation of Caspase-۳ and Caspase-۹ transcripts alongside the downregulation of Bcl-۲ expression. In addition, a statistically significant reduction in the mRNA expression levels of the immune checkpoint molecules CD۴۷ and SIGLEC۱۵ was observed following treatment. Conclusion:  The findings of this study provide novel evidence that zinc phthalocyanine-mediated photodynamic therapy simultaneously induces apoptosis while downregulating the critical immune checkpoints CD۴۷ and SIGLEC۱۵ in thyroid cancer cells. This dual mechanism of action underscores the therapeutic potential of photodynamic therapy as an effective strategy for enhancing antitumor efficacy through both direct cytotoxic effects and the potential mitigation of immune evasion. Keywords:

نویسندگان

گلناز فلاح

Department of Genetics, Ta.C., Islamic Azad University, Tabriz, Iran

مهرداد پاشازاده

Department of Medical Laboratory Sciences and Microbiology, TaMS.C., Islamic Azad University, Tabriz, Iran

ابوالفضل جعفری ثالث

Infectious Diseases Research Center, TaMS.C., Islamic Azad University, Tabriz, Iran

حبیب تجلی

Biophotonics Research Center, Ta.C., Islamic Azad University, Tabriz, Iran

سیده سمانه شهریار اسکویی

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hussein AM, Hussein KA-E, Babkair HA, Badawy M. Anti-cancer medicins ...
  • Prete A, Borges de Souza P, Censi S, Muzza M, ...
  • Cabanillas ME, McFadden DG, Durante C. Thyroid cancer. The Lancet. ...
  • Chen H, Li H, Li H, Zhang Z. Umbrella review ...
  • Nabhan F, Dedhia PH, Ringel MD. Thyroid cancer, recent advances ...
  • Ritter R. Thyroid cancer–treatment options. Master's thesis, Zagreb: University of ...
  • Boucai L, Zafereo M, Cabanillas ME. Thyroid cancer: a review. ...
  • Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, ...
  • Kwiatkowski S, Knap B, Przystupski D, Saczko J, Kędzierska E, ...
  • Zhang Y, Zheng J. Functions of immune checkpoint molecules beyond ...
  • Li B, Chan HL, Chen P. Immune checkpoint inhibitors: basics ...
  • Shafi S, Aung TN, Robbins C, Zugazagoitia J, Vathiotis I, ...
  • Xu S, Wang X, Yang Y, Li Y, Wu S. ...
  • Qiu J, Cheng Z, Jiang Z, Gan L, Zhang Z, ...
  • Carlisle JW, Leal T. Advancing immunotherapy in small cell lung ...
  • Doustvandi MA, Mohammadnejad F, Mansoori B, Mohammadi A, Navaeipour F, ...
  • Schmidt J, Kuzyniak W, Berkholz J, Steinemann G, Ogbodu R, ...
  • Yu W, Ye M, Zhu J, Wang Y, Liang C, ...
  • Vittar NBR, Awruch J, Azizuddin K, Rivarola V. Caspase-independent apoptosis, ...
  • Poh A. Siglec-۱۵: an attractive immunotherapy target. Cancer Discov. ۲۰۲۰;۱۰(۱):۷-۸ ...
  • Garg AD, Nowis D, Golab J, Vandenabeele P, Krysko DV, ...
  • Kroemer G, Galluzzi L, Kepp O, Zitvogel L. Immunogenic cell ...
  • Karizak AZ, Salmasi Z, Gheibihayat SM, Asadi M, Ghasemi Y, ...
  • Khalaji A, Yancheshmeh FB, Farham F, Khorram A, Sheshbolouki S, ...
  • Deng H, Wang G, Zhao S, Tao Y, Zhang Z, ...
  • Han X, Chang W-w, Xia X. Immune checkpoint inhibitors in ...
  • Cramer GM, Moon EK, Cengel KA, Busch TM. Photodynamic therapy ...
  • Mitra S, Modi KD, Foster TH. Enzyme-activatable imaging probe reveals ...
  • Ye Y, Zhao S, Pang E, Tang Y, Zhu P, ...
  • نمایش کامل مراجع